Health Canada has approved Moderna's mRNA vaccine for influenza and its flu-COVID combo vaccine. This marks Canada as the first country to approve such a dual-purpose vaccine. The approval comes after extensive testing and regulatory review. The vaccine is designed to protect against both influenza and SARS-CoV-2. It is expected to be available for use in the coming months. The decision follows growing concerns about the impact of respiratory illnesses during the winter season. Public health officials have emphasized the importance of vaccination in reducing hospitalizations and deaths. The vaccine is intended for individuals aged 18 and older. It is administered as a single dose. The approval is part of Canada's broader strategy to manage public health risks. The government has been working closely with health experts to ensure vaccine safety and efficacy. This development is seen as a significant step in pandemic preparedness.